STOCK TITAN

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2022 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call on August 4, 2022, at 4:30 p.m. ET, to discuss its second quarter 2022 financial results and provide a business outlook. Participants can register for the call in advance to receive dial-in details and are encouraged to join 15 minutes early to avoid delays. A replay of the conference call will be available on PTC's website shortly after the event and archived for 30 days. The company is committed to developing treatments for rare disorders.

Positive
  • Scheduled webcast to discuss second quarter 2022 financial results.
  • Opportunity for investors to gain insights into business outlook.
Negative
  • None.

SOUTH PLAINFIELD, N.J., July 21, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its second quarter 2022 financial results and provide an update on the company's business and outlook on Thursday, Aug. 4, at 4:30 p.m. ET.

To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.

About PTC Therapeutics, Inc.

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-second-quarter-2022-financial-results-301590794.html

SOURCE PTC Therapeutics, Inc.

FAQ

When is PTC Therapeutics' second quarter 2022 financial results conference call?

PTC Therapeutics' conference call for second quarter 2022 financial results is scheduled for August 4, 2022, at 4:30 p.m. ET.

How can I listen to the PTC Therapeutics conference call?

You can access the conference call by registering through the link provided in the press release, where you will receive dial-in details.

Will a replay of the PTC Therapeutics conference call be available?

Yes, a replay of the conference call will be available approximately two hours after the call and archived on PTC's website for 30 days.

What topics will be covered in the PTC Therapeutics conference call?

The call will cover the second quarter 2022 financial results and updates on the company's business and outlook.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

3.39B
77.13M
2.34%
105.79%
6.06%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WARREN